HWM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
HWM is not a good immediate buy for a beginner long-term investor with $50,000-$100,000 to deploy right now. The business quality and growth are strong, but the stock is already extended, sentiment is mixed-to-cautious, insider selling is rising, and the technical setup does not support chasing the pre-market move. If you are impatient and want an entry now, this is a hold rather than a fresh buy.
The trend is still constructive over the longer term, but the near-term technical picture is neutral to weak. MACD histogram is negative at -1.325 and still below zero, RSI_6 is 48.55, which is neutral, and moving averages are converging rather than showing a clean breakout. Price is 244.1 pre-market, just above the pivot at 245.693 and below resistance at 255.404, so it is not in a strong breakout zone. The stock also has a bearish short-term pattern read with expected downside pressure in the next day/week/month based on similar candlestick behavior.
Howmet delivered strong Q4 2025 financial growth: revenue up 14.65% YoY, net income up 18.47% YoY, EPS up 19.48% YoY, and gross margin improved to 31.5%. Analysts broadly remain positive overall, with multiple Buy/Outperform ratings and several raised targets. The company benefits from commercial aerospace exposure, defense exposure, and the recent Consolidated Aerospace Manufacturing acquisition, which should expand capabilities and support longer-term growth.
Insiders are selling, and selling increased 391.50% over the last month, which is a meaningful negative signal. Hedge funds are neutral with no significant trend over the last quarter. Analyst opinion is not uniformly bullish: Wells Fargo initiated at Equal Weight with a $240 target, and UBS is Neutral. Citi cut its target to $271 from $283, and Goldman lowered its target to $228 from $257, showing some valuation caution. No AI Stock Picker or SwingMax signal is present today, so there is no proprietary buy trigger.
Latest quarter: Q4 2025. Financials were strong and accelerating. Revenue rose to $2.168 billion, up 14.65% YoY. Net income increased to $372 million, up 18.47% YoY. EPS reached $0.92, up 19.48% YoY. Gross margin expanded to 31.5%, up 12.62% YoY. This is a healthy growth quarter with clear margin improvement, which supports the long-term story.
Analyst trend remains constructive but has become more mixed recently. Positive calls and higher targets from RBC ($300), BofA ($300), JPMorgan ($265), BTIG ($275), Bernstein ($280), and Citi ($271) show continued confidence. However, Wells Fargo initiated at Equal Weight with a $240 target, UBS is Neutral at $260, and Goldman reduced its target to $228. Wall Street’s pros: strong execution, durable aerospace demand, share gains, and margin expansion. Cons: valuation is high, upside may be more limited from here, and some firms see less room for outperformance versus peers.
